Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
552.65
|
|
Change (%)
|
19.75 (3.71%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
530.25
-
560.85
|
|
52-Week Range (RS)
|
287.00
-
606.95
|
|
Beta (1 Year)
|
0.77
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Loss of Share Certificates |
| Solara Active Pharma Sciences completes divestment of 100% stake in SeQuent Penems |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Disclosure under SEBI Takeover Regulations |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Other General Purpose |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Shareholders meeting |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Sale / Purchase of shares |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Trading Window |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Updates |
| Board of Solara Active Pharma Sciences approves sale of subsidiary - SeQuent Penems |
| Solara Active Pharma Sciences Ltd - Solara Active Pharma Sciences Limited - Updates |
|
|
|
| Incoporation Year : 2017 |
| Chairman : Aditya Puri |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Solara Active Pharma Sciences Ltd
201 Devavrata Sector 17 Vashi,
Navi Mumbai,
Mumbai,
Maharashtra-400703 |
Phone:91-22-27892924
Fax:91-22-27892942 |
| E-Mail : investors@solara.co.in |
| URL : http://www.solara.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
26-Apr-2024 |
541.65 |
2.03 |
| 1Month |
03-Apr-2024 |
411.85 |
34.19 |
| 3Month |
05-Feb-2024 |
396.90 |
39.24 |
| 6Month |
03-Nov-2023 |
340.15 |
62.47 |
| 1Year |
03-May-2023 |
377.10 |
46.55 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Aditya Birla SL Flexi Cap Fund |
0.08 |
15.58 |
| Aditya Birla SL Midcap Fund |
0.10 |
4.82 |
| Aditya Birla SL Manufacturing Equity F.. |
0.28 |
2.41 |
| Motilal Oswal S&P BSE Healthcare ETF |
0.06 |
0.01 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceuticals Industries Ltd |
1,508.40 |
-0.66 |
1,638.70 |
922.55 |
361,915.69 |
| Cipla Ltd |
1,424.75 |
0.37 |
1,519.00 |
897.70 |
115,033.60 |
| Dr Reddys Laboratories Ltd |
6,349.95 |
0.98 |
6,505.50 |
4,383.40 |
105,928.76 |
| Zydus Lifesciences Ltd |
997.00 |
0.90 |
1,031.30 |
482.55 |
100,321.53 |
| Mankind Pharma Ltd |
2,314.30 |
-0.85 |
2,488.65 |
1,240.75 |
92,708.18 |
|
|
|
|